Evidence map›Paper›PMID 30283426›Full record

ArticleFrontiers in microbiology2018

A Class 1 Histone Deacetylase as Major Regulator of Secondary Metabolite Production in

Angelo Pidroni, Birgit Faber, Gerald Brosch, Ingo Bauer, Stefan Graessle

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Metabolic Engineering for Gibberellic Acid Production inMolecules (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Molecular regulation of fungal secondary metabolism.World journal of microbiology & biotechnology · 2023
    Review
  17. Characterization and engineering of the xylose-inducibleMetabolic engineering communications · 2022
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Angelo PidroniDivision of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.
Birgit FaberDivision of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.
Gerald BroschDivision of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.
Ingo BauerDivision of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.
Stefan GraessleDivision of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.
Innsbruck Medical University · ATUniversität Innsbruck · AT

Funding

Austrian Science Fund FWF P 24803
6 · The paper itself

Abstract

An outstanding feature of filamentous fungi is their ability to produce a wide variety of small bioactive molecules that contribute to their survival, fitness, and pathogenicity. The vast collection of these so-called secondary metabolites (SMs) includes molecules that play a role in virulence, protect fungi from environmental damage, act as toxins or antibiotics that harm host tissues, or hinder microbial competitors for food sources. Many of these compounds are used in medical treatment; however, biosynthetic genes for the production of these natural products are arranged in compact clusters that are commonly silent under growth conditions routinely used in laboratories. Consequently, a wide arsenal of yet unknown fungal metabolites is waiting to be discovered. Here, we describe the effects of deletion of

Indexed as

antifungalsAspergillusfilamentous fungihistone deacetylaseshistone modifications and chromatin structuresecondary metabolitestranscription factors

Identifiers

PMID30283426
PMCPMC6156440
OpenAlexW2891318185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.